Head-to-Head Against Pembrolizumab: Innovent Announces First Patient Dosed in the First Pivotal Study of IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Melanoma

CARsgen's Claudin18.2 CAR-T Therapy Satri-cel Granted Breakthrough Therapy Designation by the NMPA

Pulnovo Medical Announces Closing of Nearly $100 Million Series C Financing

Yuwell Medical Joins CFA Team China as Official Partner: Elevating Health Celebrating Sport

Yuewen Global IP Awards Creator Forum: The Rise of China's Global IP Ecosystem

Patriot Announces Discovery of a Large Cesium Zone at Shaakichiuwaanaan